<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03357809</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A01591-50</org_study_id>
    <nct_id>NCT03357809</nct_id>
  </id_info>
  <brief_title>Endoscopic Resection in Gastro-Esophageal Reflux Disease</brief_title>
  <acronym>RESECT-RGO</acronym>
  <official_title>Monocentric Study Evaluating the Efficiency and Safety of Anti-reflux Mucosectomy ARMS for the Gastro-Esophageal Reflux Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital St. Joseph, Marseille, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital St. Joseph, Marseille, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently patients with gastroesophageal reflux disease (GERD) are treated with proton pump
      inhibitors (PPIs). This long-term PPI treatment would likely increase the risk of pulmonary
      and digestive infections and would not prevent evolution to adenocarcinoma of Barrett's
      Esophagus. Surgical fundoplication is generally recommended when symptoms are poorly
      controlled with PPIs and considered as standard treatment despite celioscopy risk. A variety
      of endoscopic techniques for the treatment of GERD has been proposed to obtain non-surgical
      control. These endoscopic techniques aim to bring the tissues closer to the Œsogastric (JOG)
      junction. But a low response rate has been demonstrated with these techniques.

      H. Inoue (inventor of the anti-reflux mucosectomy 20 years ago) and his team postulated that
      the reflux symptoms would be reduced by creating a relative restriction of gastric cardia.
      The healing of the mucosectomy zone led to restriction of gastric cardia. This observation
      suggested that ARMS could represent an effective anti-reflux procedure with the advantage
      that no prostheses would be left in situ.

      Few studies have evaluated this new endoscopic technique. The purpose of this study is to
      evaluate the feasibility and safety of gastric mucosectomy for patients with GERD resistant
      to medical treatment or requiring long-term maintenance medical treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a monocentric prospective therapeutic study. Patients will be recruited in
      hepato-gastroenterology department of Saint Joseph Hospital (Marseille). A first clinical,
      endoscopic and PH impedance evaluation will be made. Mucosectomy will be scheduled depending
      on the results of the review.

      The patients will be followed for 2 years with esophageal and gastric PH-impedance monitoring
      at 6 months and 24 months. Health related quality of life questionnaires will be completed
      before ARMS, 6 and 24 months after mucosectomy.

      The characteristics of the patients will be compared to evaluate the % of responders and
      non-responders
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2017</start_date>
  <completion_date type="Anticipated">April 10, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients no longer requiring medical treatment at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Suggest that endoscopic treatment would allow the cessation of medical treatment in 50% of cases Rate of patients no longer requiring medical treatment at 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of improvement in quality of life measured by the score obtained in the GERD-HRQL questionnaire evaluating the impact of GERD on quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of gastric PH</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement of gastric PH metric dosages.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation for morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of all observed complications in per and post immediate procedure (up to 30 minutes). The delayed morbidity of the procedure for the study will be defined by the rate of complications occurring after the examination and up to 30 days. Specially, the following events will be studied: digestive hemorrhage and digestive perforation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>GERD</condition>
  <condition>Gastro Esophageal Reflux</condition>
  <arm_group>
    <arm_group_label>Endoscopic treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ENDOSCOPIC MUCOSAL RESECTION AT DAY 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic mucosal resection</intervention_name>
    <description>Mucosectomy performed at day 1. Endoscopic mucosal resection (EMR) and or endoscopic submucosal dissection (ESD), is at least 3 cm long. The mucosal resection is carried out along the side of the small curvature of the stomach, in order to preserve a valve of the cardia at the level of the large curvature of the stomach.
A coloured solution is injected into the submucosa following markers. The correct submucosal injection is confirmed by the lifting of the mucosal surface. A submucosal dissection is carried out using the dual knife. The mucosectomy is repeatedly performed until the mucosal zone is completely resected. The choice of the resection technique will depend on the anatomy of the patient.</description>
    <arm_group_label>Endoscopic treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with GERD resistant to medical treatment, or requiring daily long-term medical
             treatment

        Exclusion Criteria:

          -  Contraindications to the realization of a upper GI endoscopy

          -  Achalasia or other esophageal motor disorders

          -  Voluminous hiatal hernia Haemorrhagic, haemostasis or coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arthur Laquière, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>French Society of Digestive Endoscopy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arthur Laquière, MD</last_name>
    <phone>0491808207</phone>
    <phone_ext>33</phone_ext>
    <email>alaquiere@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence Lecomte</last_name>
    <phone>0491808207</phone>
    <phone_ext>33</phone_ext>
    <email>llecomte@hopital-saint-joseph.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>LAQUIERE</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Laquière, MD</last_name>
      <phone>0491808207</phone>
      <phone_ext>33</phone_ext>
      <email>alaquiere@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Laurence Lecomte</last_name>
      <phone>0491808207</phone>
      <phone_ext>33</phone_ext>
      <email>llecomte@hopital-saint-joseph.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Arthur Laquière, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L; LOTUS Trial Collaborators. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011 May 18;305(19):1969-77. doi: 10.1001/jama.2011.626.</citation>
    <PMID>21586712</PMID>
  </results_reference>
  <results_reference>
    <citation>Cicala M, Emerenziani S, Guarino MP, Ribolsi M. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol. 2013 Oct 21;19(39):6529-35. doi: 10.3748/wjg.v19.i39.6529. Review.</citation>
    <PMID>24151377</PMID>
  </results_reference>
  <results_reference>
    <citation>Kellokumpu I, Voutilainen M, Haglund C, Färkkilä M, Roberts PJ, Kautiainen H. Quality of life following laparoscopic Nissen fundoplication: assessing short-term and long-term outcomes. World J Gastroenterol. 2013 Jun 28;19(24):3810-8. doi: 10.3748/wjg.v19.i24.3810.</citation>
    <PMID>23840119</PMID>
  </results_reference>
  <results_reference>
    <citation>Marret H, Pierre F, Chapron C, Perrotin F, Body G, Lansac J. [Complications of laparoscopy caused by trocars. Preliminary study from the national registry of the French Society of Gynecologic Endoscopy]. J Gynecol Obstet Biol Reprod (Paris). 1997;26(4):405-12. French.</citation>
    <PMID>9265066</PMID>
  </results_reference>
  <results_reference>
    <citation>Rickenbacher N, Kötter T, Kochen MM, Scherer M, Blozik E. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc. 2014 Jan;28(1):143-55. doi: 10.1007/s00464-013-3140-z. Epub 2013 Sep 10. Review. Erratum in: Surg Endosc. 2014 Jun;28(6):2002.</citation>
    <PMID>24018760</PMID>
  </results_reference>
  <results_reference>
    <citation>Mahmood Z, Byrne PJ, McMahon BP, Murphy EM, Arfin Q, Ravi N, Weir DG, Reynolds JV. Comparison of transesophageal endoscopic plication (TEP) with laparoscopic Nissen fundoplication (LNF) in the treatment of uncomplicated reflux disease. Am J Gastroenterol. 2006 Mar;101(3):431-6.</citation>
    <PMID>16542276</PMID>
  </results_reference>
  <results_reference>
    <citation>Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014 Jun 28;20(24):7730-8. doi: 10.3748/wjg.v20.i24.7730. Review.</citation>
    <PMID>24976710</PMID>
  </results_reference>
  <results_reference>
    <citation>Feretis C, Benakis P, Dimopoulos C, Dailianas A, Filalithis P, Stamou KM, Manouras A, Apostolidis N. Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD. Gastrointest Endosc. 2001 Apr;53(4):423-6.</citation>
    <PMID>11275880</PMID>
  </results_reference>
  <results_reference>
    <citation>Cicala M, Gabbrielli A, Emerenziani S, Guarino MP, Ribolsi M, Caviglia R, Costamagna G. Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux. Gut. 2005 Feb;54(2):183-6.</citation>
    <PMID>15647177</PMID>
  </results_reference>
  <results_reference>
    <citation>Wong RF, Davis TV, Peterson KA. Complications involving the mediastinum after injection of Enteryx for GERD. Gastrointest Endosc. 2005 May;61(6):753-6.</citation>
    <PMID>15855987</PMID>
  </results_reference>
  <results_reference>
    <citation>Chuttani R, Sud R, Sachdev G, Puri R, Kozarek R, Haber G, Pleskow D, Zaman M, Lembo A. A novel endoscopic full-thickness plicator for the treatment of GERD: A pilot study. Gastrointest Endosc. 2003 Nov;58(5):770-6.</citation>
    <PMID>14595322</PMID>
  </results_reference>
  <results_reference>
    <citation>Cadière GB, Buset M, Muls V, Rajan A, Rösch T, Eckardt AJ, Weerts J, Bastens B, Costamagna G, Marchese M, Louis H, Mana F, Sermon F, Gawlicka AK, Daniel MA, Devière J. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg. 2008 Aug;32(8):1676-88. doi: 10.1007/s00268-008-9594-9.</citation>
    <PMID>18443855</PMID>
  </results_reference>
  <results_reference>
    <citation>Satodate H, Inoue H, Yoshida T, Usui S, Iwashita M, Fukami N, Shiokawa A, Kudo SE. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report. Gastrointest Endosc. 2003 Aug;58(2):288-92.</citation>
    <PMID>12872107</PMID>
  </results_reference>
  <results_reference>
    <citation>Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, Hayee B, Eleftheriadis N, Kudo SE. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27(4):346-351.</citation>
    <PMID>25330784</PMID>
  </results_reference>
  <results_reference>
    <citation>Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996 Sep;183(3):217-24.</citation>
    <PMID>8784314</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2017</study_first_submitted>
  <study_first_submitted_qc>November 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2017</study_first_posted>
  <last_update_submitted>November 24, 2017</last_update_submitted>
  <last_update_submitted_qc>November 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital St. Joseph, Marseille, France</investigator_affiliation>
    <investigator_full_name>Arthur Laquiere</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

